Continued growth. Emerging headwinds.
307 million international arrivals in Q1 2026, a record 5.2 billion air passengers forecast for the full year — but the Middle East conflict and five structural IATA risk factors are moderating momentum.
Sources: UN Tourism Barometer (June 2026) · IATA Global Outlook (December 2025) · WTTC 2025. Data current as of June 2026. Analysed by VacZine Analytics in the context of travel vaccine demand and travel health market access.
Q1 2026 · +2% vs Q1 2025
full year 2026 · new global record
2026 · unprecedented high
2026 forecast · 3.9% net margin
A record year for aviation, with a moderating pace of arrival growth.
IATA forecasts 5.2 billion air passengers in 2026, a new global record. International tourist arrivals grew 2% in Q1 2026 — continued expansion, but below the 4–5% seen across 2025.
Unprecedented
Industry profit
IATA's five key risks for 2026.
Beyond the immediate impact of the Middle East conflict, IATA has identified five structural and cyclical risks that could constrain global aviation growth across 2026 and beyond.
What this means for travel vaccine demand.
Continued high passenger volumes — even at a moderating growth rate — sustain strong underlying demand for travel health services. Headwinds introduce nuance: route disruption, destination shifts and price sensitivity all shape where and how that demand materialises.
Volume floor remains high
5.2 billion air passengers in 2026 means the addressable population for pre-travel consultations and vaccines remains at historically elevated levels, even with growth moderating to 3–4%.
Middle East disruption reshapes corridors
Regional aviation disruption in the Middle East compresses certain high-risk travel corridors. Destination substitution — travellers rerouting to alternative destinations — may shift demand across vaccine categories.
Capacity constraints favour premium routes
Aircraft delivery backlogs and record load factors favour higher-yield, longer-haul routes where travel vaccine requirements are typically more complex and consultation uptake is higher.
Discuss the travel health opportunity
VacZine Analytics covers travel vaccine pipeline, payer access and population demand across global markets. Contact us to discuss how these travel trends shape your commercial strategy.
← Back to homepage Request a briefing